Greg Beilman, MD received 2 new research grants from the US Department of Defense.

A Randomized Trial of Intraportal Alone Versus Intraportal and Extraportal Transplantation of Pancreatic Islets After Total Pancreatectomy for Chronic Pancreatitis, PI Greg Beilman, US Army Medical Research and Materiel Command, 4yrs, $1.9 M

Developing MG53 as a Novel Protein Therapeutic for Acute Lung Injury, Ohio State University, US Army Medical Research and Materiel Command, $3.5 M, 4yrs